✦ LIBER ✦

Constipation in Parkinson's disease

✍ Scribed by Jost, W. H. ;Schimrigk, K.

Book ID: 105312081
Publisher: Springer-Verlag
Year: 1991
Tongue: English
Weight: 485 KB
Volume: 69
Category: Article
ISSN: 1432-1440
DOI: 10.1007/bf01798536

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisapride treatment of constipation in p

Cisapride treatment of constipation in parkinson's disease

✍ Dr. W. H. Jost; K. Schimrigk 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 645 KB

## Abstract Constipation, a frequent symptom in Parkinson's disease (PD), is probably caused by degeneration of the autonomic nervous system, particularly the myenteric plexus. Cisapride is a drug that causes increased release of acetylcholine in the myenteric plexus. In a pilot study, cisapride th

Constipation triggered the malignant syn

Constipation triggered the malignant syndrome in Parkinson’s disease

✍ Emina Ogawa; Ryuji Sakakibara; Masahiko Kishi; Fuyuki Tateno 📂 Article 📅 2011 🏛 Springer Milan 🌐 English ⚖ 314 KB

Severe constipation in parkinson's disea

Severe constipation in parkinson's disease relieved by botulinum toxin

✍ Dr. Alberto Albanese; Giorgio Maria; Anna Rita Bentivoglio; Giuseppe Brisinda; E 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB

## Abstract A parkinsonian patient with severe outlet‐type constipation was treated with injection of botulinum toxin into the puborectalis muscle. A total of 30 units (Botox) was injected in two sites. Resting anal pressure, maximum voluntary contraction, and pressure on straining were evaluated b

Constipation in parkinson's disease: Obj

Constipation in parkinson's disease: Objective assessment and response to psyllium

✍ Waseem Ashraf; Ronald F. Pfeiffer; Faye Park; John Lof; Dr. Eamonn M. M. Quigley 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 571 KB

We evaluated the reliability of patient history and the effect of psyllium on symptoms and colorectal function in 12 patients with Parkinson's disease (PD) and constipation. In all but two, constipation anteceded the development of parkinsonian symptoms. A comparison with prospectively obtained stoo

Tegaserod (Zelnorm) for the treatment of

Tegaserod (Zelnorm) for the treatment of constipation in Parkinson's disease

✍ Kelly L. Sullivan; Joseph F. Staffetti; Robert A. Hauser; Peter B. Dunne; Theres 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 1 views

## Abstract We performed a double‐blind randomized placebo‐controlled pilot study to determine the efficacy of tegaserod (Zelnorm) in treating constipation in 15 patients with Parkinson's disease (PD). There was a trend for improvement in the Subject's Global Assessment (SGA) of satisfaction with b

Excess burden of constipation in Parkins

Excess burden of constipation in Parkinson's disease: A pilot study

✍ Julie Kaye; Heather Gage; Alan Kimber; Lesley Storey; Patrick Trend 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB 👁 1 views

An analysis was undertaken of clinic-based questionnaires that asked people with Parkinson's disease and a control group of older people without a known neurological condition about their experiences of constipation. People with Parkinson's disease report higher constipation on a validated objective